Product testing

FILE - In this Friday, June 12, 2020 file photo, a doctor holds a bag of blood plasma donated by a COVID-19 survivor at at blood bank in La Paz, Bolivia. Mayo Clinic researchers are reporting a strong hint that blood plasma from COVID-19 survivors helps other patients recover. But it's not proof, and some experts worry if, amid clamor for the treatment, they'll ever get a clear answer. (AP Photo/Juan Karita)
August 14, 2020 - 3:38 pm
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear answer. More than 64,000 patients in the U.S. have been given convalescent...
Read More
A medical worker gives coronavirus vaccine candidate to a volunteer during a trial at a community health center in Bandung, West Java, Indonesia, Friday, Aug. 14, 2020. Indonesia's only vaccine production company has started this week a so-called phase 3 clinical trials to test a potential coronavirus vaccine developed by a Chinese company. (AP Photo/Kusumadirezza)
August 14, 2020 - 5:52 am
JAKARTA, Indonesia (AP) — More people in Indonesia rolled up their sleeves Friday to test a potential coronavirus vaccine developed by a Chinese company. The Indonesian government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech in early...
Read More
In this May 2020 photo provided by Eli Lilly, researchers prepare cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. (David Morrison/Eli Lilly via AP)
August 12, 2020 - 3:05 pm
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them. Antibodies are proteins the body makes when an infection occurs; they...
Read More
FILE In this file photo taken on Thursday, July 9, 2020, Russian President Vladimir Putin gestures during a video conference meeting at the Novo-Ogaryovo residence outside Moscow in Moscow, Russia. Putin says that a coronavirus vaccine developed in the country has been registered for use and one of his daughters has already been inoculated. Speaking at a government meeting Tuesday, Aug. 11, 2020, Putin said that the vaccine has proven efficient during tests, offering a lasting immunity from the coronavirus. (Alexei Druzhinin, Sputnik, Kremlin Pool Photo via AP, File)
August 11, 2020 - 5:45 am
MOSCOW (AP) — Russia on Tuesday became the first country to officially register a coronavirus vaccine and declare it ready for use, despite international skepticism. President Vladimir Putin said that one of his daughters has already been inoculated. Putin emphasized that the vaccine underwent the...
Read More
A child grimaces as a health worker takes a nasal swab sample for COVID- 19 testing through rapid antigen methodology, in New Delhi, India , Friday, Aug. 7, 2020. As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. (AP Photo/Manish Swarup)
August 07, 2020 - 5:16 am
NEW DELHI (AP) — As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. Even as India has...
Read More
In this photo made from footage provided by the Russian Defense Ministry on Wednesday, July 15, 2020, medical workers in protective gear prepare to draw blood from volunteers participating in a trial of a coronavirus vaccine at the Budenko Main Military Hospital outside Moscow, Russia. Russia is boasting that it’s about to be the first country to approve a COVID-19 vaccine, but scientists worldwide are sounding the alarm that the headlong rush could backfire. (Russian Defense Ministry Press Service via AP)
August 07, 2020 - 3:02 am
MOSCOW (AP) — Russia boasts that it’s about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire...
Read More
Employees of the Lavakar car wash pose for a group portrait in Mexico City, Friday, July 31, 2020. The workers said the shop was closed for three months during the COVID-19 related lockdown, and now after reopening only wash about 10 cars a day, compared to 30 before the lockdown. (AP Photo/Marco Ugarte)
July 31, 2020 - 10:23 pm
MEXICO CITY — Mexico has become the country with the third most COVID-19 deaths in the world, behind the United States and Brazil. Mexican health officials said Friday there were 688 deaths for the latest 24-hour reporting period, pushing the country’s total to 46,688. That put Mexico just ahead of...
Read More
FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)
July 31, 2020 - 12:46 pm
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2.1 billion “for...
Read More
Professor Robin Shattock the Head of Mucosal Infection and Immunity within the Department of Medicine at Imperial College in London, Thursday, July 30, 2020. Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in those vaccinated so far. Dr. Robin Shattock told the Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in a small number of participants and would now be expanding the trial to about 300 people, including those over 75. (AP Photo/Kirsty Wigglesworth)
July 30, 2020 - 2:15 pm
LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr. Robin Shattock, a professor at the college, told The Associated...
Read More
President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)
July 27, 2020 - 6:23 pm
WASHINGTON (AP) — President Donald Trump’s handling of the coronavirus pandemic put his political fate in grave jeopardy. Now he’s hoping to get credit for his administration’s aggressive push for a vaccine -– and crossing his fingers that one gets approved before Election Day. Trump and Vice...
Read More

Pages